OUTCOMES WITH USE OF ANTI-THYMOCYTE GLOBULIN FOR TREATMENT OF ACUTE TCMR IN STANDARD RISK KIDNEY TRANSPLANTATION

  Back

E-Poster

https://storage.unitedwebnetwork.com/files/1099/18cb3e9b67a548f298b87cbeeeb0c988.pdf

Abstract Title

OUTCOMES WITH USE OF ANTI-THYMOCYTE GLOBULIN FOR TREATMENT OF ACUTE TCMR IN STANDARD RISK KIDNEY TRANSPLANTATION

First Name *

RABEEA

Last Name *

AZMAT

Co-author 1

Janette Chu Janette.Chu@mft.nhs.uk Manchester Royal Infirmary Renal Medicine Manchester

Co-author 2

Jitesh Jeswani jiteshjeswani@ymail.com Nephron Kidney Hospital Renal Medicine Nagpur

Co-author 3

Shiv Bhutani shiv.bhutani@mft.nhs.uk Manchester Royal Infirmary Renal Medicine Manchester

Co-author 4

Durga AK Kanigicherla Durga.Kanigicherla@mft.nhs.uk Manchester Royal Infirmary Renal Medicine Manchester

Co-author 5

 

Co-author 6

 

Co-author 7

 

Co-author 8

 

Co-author 9

 

Co-author 10

 

Co-author 11

 

Co-author 12

 

Co-author 13

 

Co-author 14

 

Co-author 15